HomeInsightsStock Comparison

Ajanta Pharma Ltd vs Alembic Pharmaceuticals Ltd Stock Comparison

Ajanta Pharma Ltd vs Alembic Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Ajanta Pharma Ltd is ₹ 2745 as of 22 Jul 12:24.
  • The P/E Ratio of Ajanta Pharma Ltd changed from 25.6 on March 2020 to 35.7 on March 2025 . This represents a CAGR of 5.70% over 6 yearsThe P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.3 on March 2025 . This represents a CAGR of 17.16% over 6 years.
  • The Market Cap of Ajanta Pharma Ltd changed from ₹ 11921 crore on March 2020 to ₹ 32708 crore on March 2025 . This represents a CAGR of 18.32% over 6 yearsThe Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 18265 crore on March 2025 . This represents a CAGR of 10.45% over 6 years.
  • The revenue of Ajanta Pharma Ltd for the Mar '25 is ₹ 1188 crore as compare to the Dec '24 revenue of ₹ 1176 crore. This represent the growth of 1.02% The revenue of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 1783 crore as compare to the Dec '24 revenue of ₹ 1702 crore. This represent the growth of 4.77%.
  • The ebitda of Ajanta Pharma Ltd for the Mar '25 is ₹ 315.26 crore as compare to the Dec '24 ebitda of ₹ 351.27 crore. This represent the decline of -10.25% The ebitda of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 285.46 crore as compare to the Dec '24 ebitda of ₹ 270.08 crore. This represent the growth of 5.69%.
  • The net profit of Ajanta Pharma Ltd changed from ₹ 208.12 crore to ₹ 225.26 crore over 8 quarters. This represents a CAGR of 4.04% The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 156.63 crore over 8 quarters. This represents a CAGR of 13.96% .
  • The Dividend Payout of Ajanta Pharma Ltd changed from 25.99 % on March 2020 to 38.28 % on March 2025 . This represents a CAGR of 6.67% over 6 yearsThe Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 42.97 % on March 2025 . This represents a CAGR of 14.12% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ajanta Pharma Ltd

  • Ajanta Pharma Limited is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa.
  • The Company is involved in development, manufacturing and marketing of quality finished dosages in domestic and international markets.
  • It produces a comprehensive range of specialty products targeting different therapeutic segments.
  • It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company's business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
  • The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia.

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals Limited manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Limited was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Limited.
  • The company is engaged in pharmaceuticals business.
  • As per the Scheme of Arrangement, the 'Pharmaceutical Undertaking' of Alembic Limited got demerged and transferred to the Company with effect from April 1, 2010. In April 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

Ajanta Pharma Ltd News Hub

News

Ajanta Pharma to convene board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 28 July 2025...

Read more

17 Jul 2025 10:29

News

Ajanta Pharma Ltd spurts 0.96%, up for five straight sessions

Ajanta Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2814...

Read more

17 Jul 2025 13:00

News

Ajanta Pharma Ltd spurts 1.6%, gains for third straight session

Ajanta Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs ...

Read more

04 Jul 2025 13:05

News

Ajanta Pharma to convene AGM

Ajanta Pharma announced that the 46th Annual General Meeting(AGM) of the company will be h...

Read more

13 Jun 2025 09:37

News

Ajanta Pharma to discuss results

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 April 202...

Read more

22 Apr 2025 17:19

News

Ajanta Pharma Ltd spurts 2.5%, up for five straight sessions

Ajanta Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2786...

Read more

03 Feb 2025 13:00

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharmaceuticals to convene board meeting

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 ...

Read more

21 Jul 2025 17:03

News

Alembic Pharmaceuticals appoints Sr. Vice President - SCM & Operations

Alembic Pharmaceuticals has appointed Dr. Sachin Ghosalkar is appointed as Sr. Vice Presid...

Read more

21 Jul 2025 14:08

News

Alembic Pharma appoints G. Krishnan as new CFO

Krishnan is a seasoned finance professional with over 22 years of experience across the ph...

Read more

07 Jul 2025 14:58

News

Alembic Pharmaceuticals announces acquisition of Utility Therapeutics

Alembic Pharmaceuticals Inc., wholly owned subsidiary of Alembic Pharmaceuticals has acqui...

Read more

03 Jul 2025 09:15

News

Alembic Pharma inks deal to acquire Utility Therapeutics for $12 million

Utility Therapeutics is involved in the development and approval of two brand pharmaceutic...

Read more

03 Jul 2025 10:40

News

Alembic Pharma jumps after receiving USFDA nod for Doxorubicin Hydrochloride Injection

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

30 Jun 2025 10:12

SWOT Analysis Of Ajanta Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ajanta Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ajanta Pharma Ltd and Alembic Pharmaceuticals Ltd

Which company has a larger market capitalization, Ajanta Pharma Ltd or Alembic Pharmaceuticals Ltd?

Market cap of Ajanta Pharma Ltd is 34,678 Cr while Market cap of Alembic Pharmaceuticals Ltd is 20,168 Cr

What are the key factors driving the stock performance of Ajanta Pharma Ltd and Alembic Pharmaceuticals Ltd?

The stock performance of Ajanta Pharma Ltd and Alembic Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ajanta Pharma Ltd and Alembic Pharmaceuticals Ltd?

As of July 22, 2025, the Ajanta Pharma Ltd stock price is INR ₹2776.2. On the other hand, Alembic Pharmaceuticals Ltd stock price is INR ₹1026.05.

How do dividend payouts of Ajanta Pharma Ltd and Alembic Pharmaceuticals Ltd compare?

To compare the dividend payouts of Ajanta Pharma Ltd and Alembic Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions